LRRK2, lysosome damage, and Parkinson's disease
Current Opinion in Cell Biology · 2025-04 · 93 · 102482
DOI: 10.1016/j.ceb.2025.102482 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Cell Biology, 2025-04. Verfasst von Amanda Bentley-DeSousa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06510, USA; Department of Neuroscience, Yale University School of Medic…. Hauptthemen laut MEDLINE: Parkinson Disease, Lysosomes, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aligning Science Across Parkinson's.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06510, USA; Department of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA; Program in Cellular Neuroscience, Neuro…
Förderung
- Aligning Science Across Parkinson's
Zitieren
APA
Bentley-DeSousa, A., Clegg, D., & Ferguson, S. M. (2025). LRRK2, lysosome damage, and Parkinson's disease. Current Opinion in Cell Biology, 93, 102482. https://doi.org/10.1016/j.ceb.2025.102482
Vancouver
Bentley-DeSousa A, Clegg D, Ferguson SM. LRRK2, lysosome damage, and Parkinson's disease. Current Opinion in Cell Biology. 2025;93:102482. doi:10.1016/j.ceb.2025.102482
BibTeX
@article{BentleyDeSousa2025,
author = {Bentley-DeSousa, Amanda and Clegg, Devin and Ferguson, Shawn M},
title = {LRRK2, lysosome damage, and Parkinson's disease},
journal = {Current Opinion in Cell Biology},
year = {2025},
volume = {93},
pages = {102482},
doi = {10.1016/j.ceb.2025.102482}
}
EUVIMED